NCT04885374 (CARE-TCM) is a clinical trial in Amyotrophic Lateral Sclerosis, sponsored by Dongzhimen Hospital, Beijing.

Who is sponsoring NCT04885374?

NCT04885374 is sponsored by Dongzhimen Hospital, Beijing.

What condition does NCT04885374 study?

NCT04885374 studies Amyotrophic Lateral Sclerosis.

Is NCT04885374 still recruiting?

NCT04885374 is currently recruiting now. Last updated 13 May 2021.

Last reviewed 2021-05-13 · How we verify

NCT04885374: CARE-TCM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

Recruiting now Last updated 13 May 2021

What this trial tests

trial in Amyotrophic Lateral Sclerosis in 2,000 participants. Currently enrolling.

Timeline

1 March 2021

Primary endpoint
1 May 2027

1 March 2028

Quick facts

Lead sponsor	Dongzhimen Hospital, Beijing
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 March 2021
Primary completion	1 May 2027
Estimated completion	1 March 2028
Sites	1 location across China

Conditions studied

Amyotrophic Lateral Sclerosis — all drugs for Amyotrophic Lateral Sclerosis →

Sponsor

Dongzhimen Hospital, Beijing

Who can join

18 and older, any sex, with Amyotrophic Lateral Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

China amyotrophic lateral sclerosis registry of patients with Traditional Chinese Medicine (CARE-TCM): Rationale and design.
Song Y, Li M, Sugimoto K, Han Y, et al · · 2022 · cited 7× · PMID 34699945 · DOI 10.1016/j.jep.2021.114774
Reasons and experience for patients with amyotrophic lateral sclerosis using traditional Chinese medicine: a CARE-TCM based mixed method study.
Jia Q, Song Y, Zhang C, Li M, et al · · 2024 · cited 2× · PMID 38867220 · DOI 10.1186/s12906-024-04513-2

Verify or expand the search:

Other recruiting trials for Amyotrophic Lateral Sclerosis

Currently open trials in the same condition.

NCT07502677 — Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Scle · recruiting
NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
NCT07204977 — Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) · Phase 1 · active not recruiting
NCT07290062 — A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants · Phase 1 · recruiting
NCT07259980 — A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD- · recruiting

Other Dongzhimen Hospital, Beijing trials

Trials by the same sponsor.

NCT07271732 — Songling Xuemaikang Capsules for Cerebral Small Vessel Disease · NA · not yet recruiting
NCT07342075 — Registry Study of Cerebral Small Vessel Disease · recruiting
NCT07163702 — Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke · Phase 2 · not yet recruiting
NCT06857487 — Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke · Phase 1, PHASE2 · recruiting
NCT06933238 — Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04885374 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dongzhimen Hospital, Beijing
Last refreshed: 13 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04885374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing